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Abstract
Production of transforming growth factor-β (TGFβ) by T cells is key to various aspects of 
immune homeostasis, with defects in this process causing or aggravating immune-mediated 
disorders. The molecular mechanisms that lead to TGFβ generation by T cells remain largely 
unknown. To address this issue, we take advantage of the fact that intestinal helminths stimulate T 
helper 2 (Th2) cells besides triggering TGFβ generation by T lymphocytes and regulate immune-
mediated disorders. We show that the Th2 cell-inducing transcription factor STAT6 is necessary 
and sufficient for the expression of TGFβ pro-peptide (pro-TGFβ) in T cells. STAT6 is also 
necessary for several helminth-triggered events, such as TGFβ-dependent suppression of 
alloreactive inflammation in graft-versus-host disease (GVHD), in mice. Besides STAT6, 
helminth-induced secretion of active TGFβ requires cleavage of pro-TGFβ by the endopeptidase 
furin. Thus - for the immune regulatory pathway necessary for TGFβ production by T cells - our 
results support a two-step model, comprised by STAT6 and furin.
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Introduction
Transforming growth factor-β (TGFβ) is a pleiotropic cytokine that has strong immune 
regulatory activity (1–3). Defects in TGFβ circuitries lead to an increase in inflammatory 
cytokine production, disruption of peripheral immune tolerance and an aggravated course of 
immune-mediated disorders, such as inflammatory bowel disease (IBD) or graft-versus-host 
disease (GVHD)(1, 2, 4, 5). Mice lacking TGFβ – due to deletion of either the encoding 
gene (germline or conditional) or genes that encode other components of the same signaling 
pathway – develop spontaneous inflammation and aberrant immune reactivity(1, 2). 
Restoration of TGFβ pathway in patients suffering from immune-mediated disorders, such 
as IBD helps suppress the inflammation(5, 6). Thus, the role of TGFβ in maintaining the 
balance of the peripheral immune system is non-redundant as well as essential.
TGFβ is generated as an inactive pro-peptide (pro-TGFβ) and its biological effect is 
mediated by a C-terminal cytokine produced by proteolytic cleavage from an N terminal 
latency-associated peptide (LAP)(2, 3). Analyses of several animal models have suggested 
that although TGFβ is produced by various cell types, immune regulation depends on its 
expression and activation in T lymphocytes(7, 8). Polarized T helper cells, such as Th17 
cells are shown to produce TGFβ (9). Besides conventional αβ or γδ T cells, TGFβ-
generating T lymphocytes also include Foxp3+ regulatory T cells (Treg)(3, 7, 10, 11). 
Molecular mechanisms that stimulate TGFβ production by T cells are unknown. Although 
some proteins capable of activating the TGFβ cytokine by enzymatically cleaving the 
propeptide (pro-TGFβ) – such as furin - have been identified(10, 12, 13), their physiological 
relevance in specific contexts deserve further attention and the cellular pathways that drive 
the expression of pro-TGFβ remain to be established.
One set of clues to the origins of TGFβ producing T lymphocytes is that they emerge in 
response to either antigen stimulation in the gut(14) or colonization of the intestine by 
helminths(15, 16). The latter involves the stimulation of TGFβ secretion by T cells in the 
mesenteric lymph node (MLN) and lamina propria of the intestine(17–19). Besides 
stimulating TGFβ generation, helminths stimulate Th2 pathway(20).
STAT6 is a Th2-inducing transcriptional activator. Helminths modulate cytokine production 
by immune cells and alter intestinal mucosal function in a STAT6-dependent manner(21–
23). STAT6 is activated by phosphorylation - initiated by Th2 cytokines, interleukin 4 (IL4) 
and IL13(24, 25). Once phosphorylated, STAT6 orchestrates the development or maturation 
of peripheral Th2 cells by altering the transcription of at least several hundred genes(21, 26).
In this study, we explored the role of STAT6 in helminth-induced TGFβ production and in 
the context of helminthic suppression of an immune-mediated disorder. In a model of graft-
versus-host disease (GVHD), which is a lethal alloreactive complication of bone marrow 
transplantation (BMT) and amenable to helminthic immune suppression(19), we show that 
helminth-induced pro-TGFβ production by T cells is dependent on STAT6. STAT6 is also 
required for helminth-induced and TGFβ-dependent suppression of GVHD. In addition to 
STAT6, activation of TGFβ by cleavage, though not the expression of pro-TGFβ, requires 
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the endopeptidase furin. Based on these results, we propose a model where TGFβ generating 
T cells originate from peripheral T cells with active Th2 (STAT6) signaling.
Materials and Methods
Mice and Heligmosomoides polygyrus bakeri (Hpb) administration.
Wild type (WT) C57BL/6 (H2b), WT BALB/c (H2d), STAT6–/– (H2d) and CD4 Cre (H2b) 
transgenic mice were obtained from The Jackson Laboratory (Bar Harbor, ME). Mice with 
conditional (CD4 promoter-driven) deletion of endopeptidase, furin (furinfl/fl (H2b)) and 
mice with CD2 promoter-driven expression of a constitutively active STAT6 (STAT6 VT 
(H2b)) in T cells were described before(27, 28). T cell-specific deletion of furin was 
achieved by the expression of Cre recombinase after crossing furin fl/fl and CD4 Cre mice 
as described previously(12). Helminth colonization was performed by inoculating 5–6 week-
old male WT BALB/c, STAT6–/–, STAT6 VT, furinfl/fl and CD4 Cre x furin fl/fl mice with 
150 Heligmosomoides polygyrus bakeri (Hpb) third stage larvae (L3) by oral gavage. 
Infective Hpb L3 (original specimens archived at the U.S. National Helminthological 
Collection, no. 81930) were obtained from mouse fecal cultures of eggs by the modified 
Baermann method(29) and stored at 4°C until used. Mice were maintained and used in 
accordance with the University of Iowa Animal Care and Use Committee Guidelines.
Cell purification for GVHD induction.
Donor bone marrow (BM) cells were obtained from the femurs and tibias of uninfected, 5–8 
week-old C57BL/6 mice. T-cell depleted (TCD) BM samples were prepared using mouse 
panT cell beads (Dynal Biotech) according the manufacturer’s instructions. Spleen cell 
samples from uninfected, 5–8 week-old C57BL/6 mice were magnetically enriched for 
untouched T cells (CD3+) using the T Cell Isolation Kit (Miltenyi Biotech).
Cell purification for in vitro cultures.
The expression of LAP and the production of TGFβ cytokine were assessed by purifying 
CD4+ T cells from splenic and mesenteric lymph nodes (MLN) of Hpb-infected and 
uninfected WT BALB/c, STAT6–/–, STAT6 VT, furinfl/fl, furinfl/fl x CD4 Cre mice using the 
CD4 T Cell Untouched Isolation Kit (Miltenyi Biotech). This resulted in >98% enrichment 
for CD4+ T cells (data not shown). To assess helminthic regulation of cytokine production 
by donor T cells during GVHD, donor CD3+ T cells from uninfected and Hpb-infected WT 
BALB/c or STAT6–/– BMT recipients were sorted from total splenocytes stained with anti-
CD3 FITC and anti-H2b PE 6 days after GVHD induction, using a FACS Vantage SE DiVa 
cell sorter (Becton Dickinson).
Total body irradiation (TBI) and GVHD induction.
Our studies utilized an MHC I/II mismatch (H2b→H2d), acute lethal GVHD model(30). At 
three weeks post infection, Hbp-infected and uninfected STAT6–/– recipients (H2d) 
underwent total body irradiation using a Cs137 source (a total of 850 cGy in two doses given 
four hours apart), and were administered 10×106 T cell-depleted bone marrow (TCD-BM) 
cells with or without 1.5×106 splenic T lymphocytes from uninfected C57BL/6 WT donors 
(H2b). Mice were monitored daily for survival for up to 100 days. In parallel experiments, 
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Hpb-infected and uninfected BALB/c wild-type and STAT6−/− mice were sacrificed 6 days 
after BMT for cellular and histopathological analysis.
Flow cytometry.
In experiments that did not involve BMT, spleen and MLN cells from uninfected and Hpb-
infected BALB/c WT, STAT6–/–, STAT6 VT, furinfl/fl and CD4 Cre x furinfl/fl mice were 
isolated 3 weeks post infection. Cells were suspended at 2×107 cells/ml in PBS with 2% 
FCS, and Fc receptors were blocked with a 2.4G2 mAb (Clone: 145–2C11, eBiosciences). 
Antibodies for surface staining were: anti-CD3 PE-Cy7, anti-CD3 FITC (Clone: 145–2C11, 
eBiosciences), anti-CD4 PE-Cy7 (Clone: GK1.5, eBioscience), anti-LAP PE (Clone: TW7–
20B9 BioLegend) vs. isotype IgG1κ PE and anti-GARP PE (Clone: F011–5, BioLegend). 
For intracellular Foxp3 staining, the Foxp3 staining buffer (Clone: FJK-16S, eBioscience) 
and anti-Foxp3 PE, Foxp3 PE-Cy7 and Foxp3 APC antibodies were used in accordance with 
the manufacturer’s instructions.
In experiments involving BMT, spleen and MLN cells from uninfected and Hpb-infected 
BALB/c or STAT6–/– mice were isolated on day 6 post-infection and stained as detailed 
above. These experiments utilized, in addition, anti-H2b PE, anti-H2d PE, and anti-H2b 
APC antibodies (Clones: SF1–1.1, SF1–1.1.1, AF6.88.5 BD Biosciences).
In vitro cell culture and cytokine ELISA.
MLN cells from uninfected or Hpb-infected wild-type BALB/c, STAT6−/−, STAT6 VT, 
furinfl/fl and furinfl/fl x CD4 Cre mice without GVHD were stimulated with anti-CD3 
(Clone: 145–2C11, eBioscience) and anti-CD28 (each at 1 μg/ml) (Clone: 37.51, 
eBioscience) for 48 hours in cell culture medium with 1% FCS and 1 mg/ml BSA(17, 18) 
for TGFβ ELISA and in cell culture medium with 10% FCS for interleukin 4 (IL4) ELISA 
(17, 18). The concentration of TGFβ cytokine in acidified and re-alkalinized supernatants 
was determined using antibody pairs from R&D Systems according to the manufacturer’s 
instructions, and the TGFβ concentration in the culture supernatants was subtracted from 
that in the culture medium. IFNγ and TNFα secretion was determined for sorted wild-type 
C57BL/6 donor splenic T cells (CD3+ and H2b+) from uninfected and Hpb-infected BALB/c 
WT and STAT6−/− BMT mice. Cells were stimulated with plate-bound anti-CD3 and soluble 
anti-CD28 (each at 1 μg/ml) for 48 hours in lymphocyte growth medium containing 10% 
FCS(31). Supernatants were analyzed for IFNγ, IL4 and TNFα content using antibody pairs 
from R&D Systems. Similar methods were employed to detect IFNγ and TNFα in sera from 
uninfected and Hpb-infected BALB/c WT and STAT6–/– mice 6 days after the induction of 
GVHD.
RNA isolation, reverse transcription and quantitative polymerase chain reaction (qPCR).
RNA from CD4-enriched T cells (CD4 T Cell Isolation Kit, Miltenyi Biotech) was isolated 
using TRIzol Reagent (Cat. 15596–026, Thermo Fisher Scientific). Intron sparing primers 
used in this study are displayed in Table 1. First-strand synthesis of cDNA from RNA was 
performed using SuperScript III kit (Cat. 18080–051, Thermo Fisher Scientific). Reverse 
transcription quantitative polymerase chain reaction (RT-qPCR) was carried out with 
QuantStudio 3 Real-Time PCR System (Thermo Fisher Scientific) using Power SYBR 
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Green PCR Master Mix (Cat. 4367659, Thermo Fisher Scientific Inc, USA). As an internal 
control, hypoxanthine guanine phosphoribosyl transferase (HPRT) RNA levels were used to 
normalize gene expression. Relative transcript abundance was calculated using the 2-ᐃCT 
method. Data were shown as mean ± standard deviation (SD).
Histopathology.
Six days after GVHD induction, lungs and colons from uninfected or Hpb-infected mice 
were fixed in 4% neutral buffered formalin and processed; 6 μm sections were stained with 
hematoxylin and eosin. Tissues were analyzed for GVHD-related inflammation, and the 
severity of inflammation was scored in blinded fashion by DEE(32–36). GVHD-related 
colitis was graded based on both the degree of inflammation and the frequency of crypt 
apoptosis. Inflammation was graded as none (score: 0), mild (1), moderate (2), severe 
without ulcer (3) or severe with ulcer (4). Crypt apoptosis was graded based on the presence 
of apoptotic bodies, as follows: rare (score: 0), occasional per 10 crypts (1), 2–5 per 10 
crypts (2), majority of crypts (>5) (3), majority of crypts containing more than one (4). The 
minimal score in this grading system for colonic disease was 0 and the maximum score was 
8. GVHD-related lung inflammation was graded based on the presence of perivascular 
cuffing, vasculitis, peribronchiolar cuffing and alveolar hemorrhage. The minimal score in 
this grading system for lung inflammation was 0 and the maximum was 4.
Statistical analysis.
Differences in survival between groups were determined using the Kaplan Meier log rank 
test. Differences in cell number and composition, serum IFNγ and TNFα content, IFNγ and 
TNFα generation by splenic donor T cells, TGFβ cytokine output of in vitro stimulated cell 
cultures, mean fluorescence intensity (MFI) of LAP expression and histopathological 
GVHD scores between groups were determined using Student’s t test.
Results
Helminth-induced protection from lethal GVHD requires the host STAT6 pathway.
We previously demonstrated that helminth-induced conditioning of the host suppresses 
GVHD(19). Helminths stimulate the Th2 pathway in the host(20), and do so by activating 
genes associated with Th2 development, such as the transcription factor STAT6(23, 37). A 
model of acute GVHD, in which both T cell-depleted bone marrow (TCD-BM) and splenic 
T cells from C57BL/6 WT (H2b) donors are transplanted into Hpb-colonized or uninfected 
irradiated STAT6–/– (H2d) recipients, enabled us to assess whether helminth-induced 
immune conditioning of the host requires host cell STAT6 activity. Although Hpb infection 
promotes the survival of WT BMT recipient mice (Figure 1 and (19)), this was not the case 
for STAT6–/– hosts; in STAT6−/− animals, BMT with C57BL/6 donor cells resulted in 
mortality within 40 days of BMT (Figure 1). When uninfected and Hpb-infected STAT6–/– 
or WT BALB/c BMT mice were transplanted with only WT donor TCD-BM cells (no 
splenic T cells), they survived the 100-day period of the experiment (Figure 1). This 
suggests that STAT6 expression by host cells is critical to helminth-induced protection from 
lethal GVHD, and to the helminth-induced regulation of donor T cells that cause GVHD.
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Helminth-induced protection from GVHD-mediated organ damage requires the host STAT6 
pathway.
We demonstrated previously that helminths suppress GVHD-related end-organ damage in 
lung and the colon of WT BMT mice(19). Histopathological analysis of these organs in 
uninfected STAT6–/– BMT mice revealed severe inflammation that was not improved by 
helminth infection (Figure 2A-D), although in WT BALB/c BMT mice Hpb-colonization 
suppressed inflammation (Figure 2E-H) and as we reported previously (19). These 
observations suggest that helminths require the STAT6 signaling pathway of the host to 
suppress end-organ damage associated with GVHD.
Next we investigated helminthic modulation of the generation of inflammatory cytokines by 
C57BL/6 WT donor T cells. CD3+ and H2b+ splenocytes from uninfected and Hpb-infected 
STAT6–/– or BALB/c WT BMT mice were sorted by FACS, 6 days after BMT. Our analysis 
revealed that helminths suppressed the secretion of inflammatory cytokines (IFNγ and 
TNFα) by C57BL/6 WT donor T cells, as well as serum inflammatory cytokine content, in 
WT BALB/c but not in STAT6–/– BMT recipients (Figure 3). These results imply that the 
STAT6 pathway of the host – associated with helminth-induced Th2 polarization – is critical 
for helminthic regulation of GVHD.
Helminthic induction of T cell-stimulated TGFβ secretion is dependent on STAT6.
Given that helminthic regulation of GVHD is dependent on TGFβ(19), we investigated 
whether T cell-stimulated secretion of TGFβ following colonization by Hpb is dependent on 
STAT6. To this end we stimulated MLN cells from Hpb-infected or uninfected STAT6–/– and 
WT BALB/c mice with anti-CD3 and anti-CD28 in vitro. Unlike the MLN cells from 
colonized WT mice, those from colonized STAT6–/– mice did not secrete TGFβ in response 
T-cell stimulation (Figure 4).
TGFβ is first generated as a propeptide (pro-TGFβ). The expression of pro-TGFβ can be 
determined by flow cytometry and by the quantification of mean fluorescence intensity 
(MFI) of the N-terminal portion of pro-TGFβ, the latency associated peptide (LAP)(38). We 
took advantage of this to determine whether helminthic induction of pro-TGFβ expression is 
dependent on STAT6. Pro-TGFβ content in the spleen and the MLN cell population was 
analyzed by flow cytometry in WT BALB/c mice and in STAT6−/− counterparts three weeks 
after the animals were administered 150 L3 Hpb larvae by gastric gavage. Although 
helminth infection led to an increase in LAP expression on Foxp3– CD4 T cells and Foxp3+ 
Tregs in the WT BALB/c mice, the levels of LAP on both T-cell subsets remained low in the 
STAT6–/– mice (Figure 5A and B). To determine whether helminth-induced and STAT6-
dependent increase in TGFβ expression is regulated transcriptionally, we analyzed TGFβ 
mRNA synthesis by quantitative PCR (qPCR) in purified splenic or MLN CD4 T cells from 
uninfected, Hpb-colonized STAT6−/− or WT BALB/c mice. We did not observe an increase 
in TGFβ mRNA expression after helminth infection in samples from WT mice and we also 
did not observe an increase in samples from WT mice compared to samples from STAT6−/− 
counterparts (Figure 5C).
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Cell surface expression of LAP is also dependent on cell surface protein, glycoprotein A 
repetitions predominant protein (GARP), also called thrombospondin. GARP or 
thrombospondin serves as an anchor for cell surface LAP and is involved in regulating the 
bioavailability and activation of TGFβ (39). The expression of GARP in resting splenic or 
MLN Foxp3- CD4 T cell or Foxp3+ Tregs from WT mice did not increase after helminth 
infection (Figure 5D) in parallel to an increase in LAP expression (Figure 5A and B), 
although the expression of GARP increased significantly after in vitro stimulation with anti-
CD3/28 (Supplemental Figure 1), as previously reported (40). Helminth infection was 
associated with a subtle increase in GARP expression in Foxp3+ but not Foxp3- CD4 T cells 
and same pattern of increase was evident in samples from WT BALB/c as well as STAT6−/− 
mice (Figure 5D). Hence the increase in LAP expression in T cells after helminth infection 
is not due to an increase in expression of the surface anchor protein, GARP. Together, these 
results suggest that STAT6 is critical to cellular expression of the TGFβ pro-peptide.
STAT6-dependent induction of TGFβ in the recipient is critical for the expansion of GVHD-
regulating donor Tregs.
The STAT6-dependent generation of TGFβ that follows helminth infection is critical for the 
previously observed increase in Treg expansion after BMT(19). In the spleen and MLN of 
WT BALB/c BMT mice, the population of WT donor Foxp3+ Tregs increased, in terms of 
both total number and percentage of the CD3+ population, following helminth infection 
(Figure 6 and 7), as we had shown previously(19). However, in STAT6–/– BMT recipients, 
both numbers remained low. The number of recipient Tregs – which regulate GVHD during 
the early days after BMT(41) – likewise remained low in Hpb-infected STAT6–/– recipients 
(Figure 6 and 7). Add-back of TGFβ to STAT6–/– T cell cultures restored the generation of 
Tregs (Supplemental Figure 2), as described previously(42). These findings suggest that 
STAT6-dependent induction of TGFβ generation is critical to expansion of Foxp3+ Treg 
populations that suppress GVHD.
STAT6 is necessary and sufficient to induce expression of the pro-TGFβ.
To determine whether STAT6 is sufficient to stimulate the generation of pro-TGFβ, we used 
a transgenic mouse in which T cells express a constitutively active form of STAT6 (STAT6 
VT), under the control of a CD2 promoter(28). LAP expression was higher in Foxp3– CD4 
T cells and Foxp3+ Tregs isolated from the spleen and MLN of STAT6VT+ (VT(+)) mice 
than in their VT- and WT counterparts (Figure 8A and B). Nonetheless, the secretion of 
active TGFβ cytokine by the VT+ cells was not higher than that by their VT- (VT(−)) and 
WT counterparts (Figure 9A). TGFβ mRNA content did not increase significantly in VT+ 
samples compared to their VT- counterparts, although TGFβ mRNA content was slightly 
higher in CD4 T cells from MLN samples (Figure 8C). This difference between spleen and 
MLN samples was not statistically significant (Figure 8C). We also analyzed LAP content in 
culture supernatants by ELISA. Nonetheless, the sensitivity of the ELISA was too low 
(detecting LAP concentrations >150–300 pg/ml) to permit analysis (data not shown). We 
also stained cells for T cell markers and GARP to determine whether the increase in LAP 
expression on VT+ T cells is caused by an increase in GARP expression. GARP expression 
was slightly increased in Foxp3+ CD4 Tregs – and not in Foxp3- CD4 T cells – in samples 
from VT+ mice (Figure 8D). The magnitude increase of GARP expression in Foxp3+ Tregs 
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from VT+ mice was less than the magnitude increase of LAP expression in the same T cell 
subset (Figure 8A, B and D). Although expression of a constitutively active STAT6 protein 
(STAT6 VT) increases LAP expression in Foxp3- CD4 T cells, STAT6 VT does not increase 
the expression of GARP protein in Foxp3- CD4 T cells (Figure 8A, B and D). Hence, the 
increase in LAP (pro-TGFβ) expression in T cells from STAT6 VT mice is not due to 
enhanced expression of GARP. Our results also made us draw the conclusion that STAT6-
mediated regulation of pro-TGFβ protein expression is posttranscriptionally regulated. 
Furthermore, STAT6 is necessary and sufficient to promote expression of the pro-TGFβ 
protein, but that other pathways are required for its proteolytic cleavage and secretion.
Generation of active TGFβ from pro-TGFβ requires furin.
To determine whether helminths induce an increase in TGFβ cytokine secretion in MLN 
cells from STAT6 VT+ mice, we stimulated CD3+ MLN T cells from Hpb-infected and 
uninfected STAT6 VT mice in vitro for 48 hours. As shown by ELISA, TGFβ secretion by 
STAT6 VT+ T cells increased significantly in the presence of helminths (Figure 9A). 
Helminth-induced increase in TGFβ secretion by VT+ T cells was similar to helminth-
induced increase in TGFβ secretion by VT- T cells.
Helminths can condition TGFβ immunity utilizing host pathways or their own products(43), 
and a previous study had demonstrated that T-cell-specific activation of TGFβ requires the 
endopeptidase furin(12). To explore the possibility that helminth-induced generation of 
active TGFβ requires furin, we analyzed the cellular expression of pro-TGFβ as well as the 
secretion of active TGFβ in uninfected and Hpb-infected T cells from CD4 Cre x furinfl/fl 
mice, whose T cells have a genetic deficiency for furin due to the T cell-specific activity of 
Cre recombinase. The secretion of active TGFβ remained undetectable in furin−/− CD4 T 
cell samples (Figure 9B), although helminth infection stimulated Th2 pathway - as shown by 
IL4 production - and LAP expression in MLN cells from the furinfl/fl x CD4 Cre mice 
(Figure 9C and D). The expression of furin mRNA did not increase after helminth infection 
in WT BALB/c samples, although furin mRNA content increased in splenic CD4 T cells 
from STAT6−/− mice after colonization with Hpb (Figure 9E). Furin mRNA content did not 
change significantly in splenic or MLN CD4 T cells between STAT6 VT+ and VT- samples 
(Figure 9F). Hence the expression of furin is not associated with Th2 polarization associated 
with helminth infection or the expression of a constitutively active STAT6 protein. These 
results lead us to propose a model for T cell TGFβ production in the periphery, where 
STAT6 is necessary and sufficient for the expression of pro-TGFβ and where an 
endopeptidase such as furin is required for production of the active cytokine and its secretion 
by T cells. Other cellular proteins such as GARP (thrombospondin) also play a role in 
surface expression of TGFβ.
Discussion
In this study, we took the advantage of a helminth infection model, in which T cells are 
stimulated to generate inactive pro-TGFβ, secrete active TGFβ, and undergo Th2 
maturation. Our strategy enabled us to shed light on the molecular mechanisms that lead to 
TGFβ production by T cells. First, we demonstrated that the Th2-specific transcription 
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factor STAT6 is necessary and sufficient for the generation of pro-TGFβ. Second, we 
showed that Th2-inducing transcription factor STAT6 is required for helminth-mediated 
suppression of GVHD. Third, our findings revealed that the endopeptidase furin is required 
for secretion of the cleaved and active C-terminal cytokine after helminth infection. 
Together, these results constitute evidence for the existence of a “two-step” cellular program 
that is critical for T cell TGFβ generation. The combination of furin-mediated and STAT6-
dependent TGFβ generation by T cells hints at a mechanism that might account for 
persistent activity of cellular pathways, which leads to Th2 differentiation and cellular TGFβ 
generation after helminth infection. According to this “two-step” model, T cells with active 
Th2 signaling (STAT6) develop into TGFβ generating T cells in the context of 
endopeptidase activity.
In conditions without helminth infection, Th2 cytokines and TGFβ can counter-regulate 
each other, with only one of these pathways dominating the immune response. TGFβ is a 
potent inhibitor of the Th2 pathway(1) where T cells deficient for TGFβ signaling due to T 
cell-specific over-expression of a dominant-negative TGFβ receptor II (TGFβ RII DN) 
spontaneously differentiate into Th2 cells(44, 45). After helminth infection, TGFβ - 
generated in response to Th2 stimulation - can still exert some level of inhibition on an 
induced Th2 pathway, as evident from the fact that, when T cells from TGFβ RII DN mice 
are exposed to helminths, the already robust Th2 cytokine production is further 
enhanced(46).
Likewise, elements of Th2 pathway can inhibit TGFβ-dependent cellular events. For 
example, Th2 cytokine IL4 prevents the generation of Foxp3+ Tregs from naïve CD4 T 
cells(47). IL4 activates STAT6 - and similarly - STAT6 inhibits TGFβ-dependent generation 
of Tregs(42). Nonetheless, the percentage of Tregs is reduced in STAT6–/– mice and 
increased in mice whose T cells express a constitutively active form of STAT6(48). Based on 
these studies, it has been proposed that STAT6 not only inhibits TGFβ-mediated activation 
of Tregs but also constitutes a nonredundant signal that stimulates expansion and the 
maintenance of peripheral Tregs(48). We propose that the effects of active STAT6 on Tregs 
depends on a second (cleavage) step: in the absence of furin or another endopeptidase that 
cleaves pro-TGFβ, active TGFβ will not be generated and STAT6 will inhibit the TGFβ-
dependent activation of Tregs; and in the presence of furin, TGFβ will be generated to 
stimulate the expansion of functional Tregs.
STAT6 is activated by the Th2 cytokines, IL4 and IL13, and it consecutively stimulates 
expression of the master regulator of the Th2 pathway, GATA3 (49). Activation of STAT6 or 
GATA3 can inhibit Tregs(42, 50). Nonetheless, in Hpb-infected and Th2-polarized mice, 
Foxp3+ Tregs express abundant GATA3(51) and this expression is critical to the 
maintenance of suppressive function. We showed previously that helminth-induced 
expansion of Foxp3+ Tregs and the suppression of inflammation in a BMT-based GVHD 
model is dependent on TGFβ(19). Here we build on these findings by showing that 
helminth-induced generation of TGFβ is dependent on STAT6, with constitutive STAT6 
signaling in T cells being sufficient to induce the expression of pro-TGFβ and helminth 
infection activating pro-TGFβ in a furin-dependent manner. The role of GATA3 in this 
phenomenon and in T cell TGFβ generation is unexplored.
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TGFβ production by T cells was previously characterized in the context of oral tolerance, 
where the presentation of antigen through the gut promotes the generation of T cell clones 
that produce not only TGFβ but also IL4(8). A similar outcome was observed after helminth 
infection, with T cell being stimulated to produce TGFβ and IL4(31, 46). Further studies of 
oral tolerance have shown that the delivery of antigen through the gut results in the 
generation of Tregs that express pro-TGFβ(52). These pro-TGFβ+ T cells execute T cell 
tolerance in a TGFβ-dependent manner. As pro-TGFβ is an inactive protein, it is unknown 
how Tregs that express pro-TGFβ regulate immunity in a TGFβ-dependent manner. 
Cytokine activation by endopeptidase-mediated proteolytic cleavage of pro-TGFβ provides a 
possible explanation for how pro-TGFβ expressing Tregs suppress immune responses 
through TGFβ-dependent pathways.
In our study we focused on the effects of GARP (thrombospondin) for the attachment of 
pro-TGFβ on T cell surface and on the effects of furin as an endopeptidase for cleavage of 
pro-TGFβ. However, other cellular proteins have also been shown to effect this cleavage and 
TGFβ activation. Besides GARP (thrombospondin), these cellular proteins include matrix 
metalloproteases and integrins (10, 13, 53, 54), such as αVβ8 integrin. Our results do not 
attest to an important role of GARP in STAT6-dependent increase of GARP expression on T 
cells for the following reasons: First, the magnitude increase of GARP expression does not 
parallel the STAT6-dependent fold-increase of LAP expression in Foxp3+ CD4 Tregs 
(Figures 5 and 8). Second, helminth-induced increase in GARP expression was of similar 
extent in Foxp3+ CD4 Tregs from STAT6−/− and BALB/c WT samples (Figure 5). Last, in 
Foxp3- CD4 T cells, LAP expression increased in a STAT6-dependent manner but GARP 
expression did not increase (Figures 5 and 8). The increase in GARP expression on Foxp3+ 
CD4 Tregs can be a result of Treg activation, because helminth infection activates the 
immune system in vivo and expression of STAT6 VT protein in T cells gives them an 
activated phenotype (28). Nonetheless, in vitro activation of T cells with a saturating dose of 
anti-CD3 and 28 results in a robust increase in GARP expression in both, Foxp3+ CD4 Tregs 
and Foxp3- CD4 T cells (Supplemental Figure 1). This discrepancy can be related to a 
difference between T cell activation in vivo and in vitro. It is also possible that the increase 
of GARP expression in T cell subsets, is related to other, less defined factors.
Next we focused on furin for the cleavage of TGFβ. Previous reports indicated that furin and 
integrins can have nonredundant roles in activating TGFβ in different cellular contexts(10, 
12) and our results suggest that furin is critical to helminth-induced TGFβ production by T 
cells. The involvement of multiple mechanisms might ensure that TGFβ is activated under 
various inflammatory or homeostatic conditions to prevent immune pathologies(55). This 
idea is supported by studies in mice deficient for matrix metalloproteases where cleavage of 
TGFβ and activation of the cytokine appears to be intact (56).
Interestingly, transient expression of active TGFβ in T cells via a transgene results in 
immune regulation(38), whereas its continuous expression in T lymphocytes augments T-
cell apoptosis, inhibits T-cell proliferation and leads to thymic atrophy(57). Thus a check-
point for TGFβ activation besides protein expression may be essential for regulation of the 
immune system. Expression of the activating enzyme by cells other than T lymphocytes(58) 
– which are the source of the majority of pro-TGFβ – could potentially also provide such a 
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check-point and further contribute to the complexity of TGFβ-mediated immune regulation 
that includes additional intra- and extracellular proteins to modulate TGFβ circuitries.
Collectively, the findings presented here identify a novel pathway of TGFβ production that 
opens new avenues for research. Follow-up studies on the mechanisms underlying STAT6-
mediated expression of pro-TGFβ, the activity of furin, and the contributions of other 
proteins that are capable of cleaving pro-TGFβ in various contexts involving polarized 
immune responses will lead to a deeper understanding of this multistep pathway of TGFβ 
secretion. A more concrete understanding of the key players in TGFβ regulation will have 
important implications for our understanding of immune regulation in the gut. Further in 
detail characterization of the TGFβ generation by T cells is expected to lead to the 
development of treatments, which might be effective for diseases such as lethal and 
devastating GVHD.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
Acknowledgments
This study was supported by research funds from the National Institute of Health R56 AI 116715 (MNI); R01 
HL56067, AI34495, HL11879 (BRB); R01 AI095282 (MHK), Department of Veterans Affairs BX002906 (MNI), 
BX002715 (DEE), FWO Vlaanderen G.0738.15N, Belgium (JWC), the Sigrid Juselius Foundation and the 
Academy of Finland (MP).
References
1. Li MO, and Flavell RA. TGF-beta: a master of all T cell trades. Cell. 2008;134(3):392–404. 
[PubMed: 18692464] 
2. Li MO, Wan YY, Sanjabi S, Robertson AK, and Flavell RA. Transforming growth factor-beta 
regulation of immune responses. AnnuRevImmunol. 2006;24(99–146.
3. Travis MA, and Sheppard D. TGF-beta activation and function in immunity. Annu Rev Immunol. 
2014;32(51–82. [PubMed: 24313777] 
4. Banovic T, Macdonald KP, Morris ES, Rowe V, Kuns R, Don A, Kelly J, Ledbetter S, Clouston AD, 
and Hill GR. TGF-beta in allogeneic stem cell transplantation: friend or foe? Blood. 2005;106(6):
2206–14. [PubMed: 15941908] 
5. Sedda S, Marafini I, Dinallo V, Di Fusco D, and Monteleone G. The TGF-beta/Smad System in IBD 
Pathogenesis. Inflamm Bowel Dis. 2015;21(12):2921–5. [PubMed: 26230862] 
6. Monteleone G, and Pallone F. Mongersen, an Oral SMAD7 Antisense Oligonucleotide, and Crohn’s 
Disease. N Engl J Med. 2015;372(25):2461.
7. Li MO, Wan YY, and Flavell RA. T cell-produced transforming growth factor-beta1 controls T cell 
tolerance and regulates Th1- and Th17-cell differentiation. Immunity. 2007;26(5):579–91. 
[PubMed: 17481928] 
8. Weiner HL, da Cunha AP, Quintana F, and Wu H. Oral tolerance. Immunol Rev. 2011;241(1):241–
59. [PubMed: 21488901] 
9. Gutcher I, Donkor MK, Ma Q, Rudensky AY, Flavell RA, and Li MO. Autocrine transforming 
growth factor-beta1 promotes in vivo Th17 cell differentiation. Immunity. 2011;34(3):396–408. 
[PubMed: 21435587] 
10. Worthington JJ, Kelly A, Smedley C, Bauche D, Campbell S, Marie JC, and Travis MA. Integrin 
alphavbeta8-Mediated TGF-beta Activation by Effector Regulatory T Cells Is Essential for 
Suppression of T-Cell-Mediated Inflammation. Immunity. 2015;42(5):903–15. [PubMed: 
25979421] 
Li et al. Page 11
J Immunol. Author manuscript; available in PMC 2019 November 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
11. Rezende RM, da Cunha AP, Kuhn C, Rubino S, M’Hamdi H, Gabriely G, Vandeventer T, Liu S, 
Cialic R, Pinheiro-Rosa N, et al. Identification and characterization of latency-associated peptide-
expressing gammadelta T cells. Nat Commun. 2015;6(8726.
12. Pesu M, Watford WT, Wei L, Xu L, Fuss I, Strober W, Andersson J, Shevach EM, Quezado M, 
Bouladoux N, et al. T-cell-expressed proprotein convertase furin is essential for maintenance of 
peripheral immune tolerance. Nature. 2008;455(7210):246–50. [PubMed: 18701887] 
13. Oida T, Zhang X, Goto M, Hachimura S, Totsuka M, Kaminogawa S, and Weiner HL. 
CD4+CD25- T cells that express latency-associated peptide on the surface suppress 
CD4+CD45RBhigh-induced colitis by a TGF-beta-dependent mechanism. Journal of immunology. 
2003;170(5):2516–22.
14. Chen Y, Kuchroo VK, Inobe J, Hafler DA, and Weiner HL. Regulatory T cell clones induced by 
oral tolerance: suppression of autoimmune encephalomyelitis. Science. 1994;265(5176):1237–40. 
[PubMed: 7520605] 
15. Grencis RK. Immunity to helminths: resistance, regulation, and susceptibility to gastrointestinal 
nematodes. Annu Rev Immunol. 2015;33(201–25. [PubMed: 25533702] 
16. Weinstock JV, and Elliott DE. Helminth Infections Decrease Host Susceptibility to Immune-
Mediated Diseases. J Immunol. 2014;193(7):3239–47. [PubMed: 25240019] 
17. Ince MN, Elliott DE, Setiawan T, Metwali A, Blum A, Chen HL, Urban JF, Flavell RA, and 
Weinstock JV. Role of T cell TGF-beta signaling in intestinal cytokine responses and helminthic 
immune modulation. EurJImmunol. 2009;39(7):1870–8.
18. Ince MN, Elliott DE, Setiawan T, Blum A, Metwali A, Wang Y, Urban JF, Jr, and Weinstock JV. 
Heligmosomoides polygyrus induces TLR4 on murine mucosal T cells that produce TGFbeta after 
lipopolysaccharide stimulation. JImmunol. 2006;176(2):726–9. [PubMed: 16393954] 
19. Li Y, Chen HL, Bannick N, Henry M, Holm AN, Metwali A, Urban JF, Jr., Rothman PB, Weiner 
GJ, Blazar BR, et al. Intestinal helminths regulate lethal acute graft-versus-host disease and 
preserve the graft-versus-tumor effect in mice. J Immunol. 2015;194(3):1011–20. [PubMed: 
25527786] 
20. Gause WC, and Maizels RM. Macrobiota - helminths as active participants and partners of the 
microbiota in host intestinal homeostasis. Curr Opin Microbiol. 2016;32(14–8. [PubMed: 
27116368] 
21. Elo LL, Jarvenpaa H, Tuomela S, Raghav S, Ahlfors H, Laurila K, Gupta B, Lund RJ, Tahvanainen 
J, Hawkins RD, et al. Genome-wide profiling of interleukin-4 and STAT6 transcription factor 
regulation of human Th2 cell programming. Immunity. 2010;32(6):852–62. [PubMed: 20620947] 
22. Metwali A, Blum A, Elliott DE, and Weinstock JV. Interleukin-4 receptor alpha chain and STAT6 
signaling inhibit gamma interferon but not Th2 cytokine expression within schistosome 
granulomas. Infect Immun. 2002;70(10):5651–8. [PubMed: 12228294] 
23. Madden KB, Yeung KA, Zhao A, Gause WC, Finkelman FD, Katona IM, Urban JF, Jr., and Shea-
Donohue T. Enteric nematodes induce stereotypic STAT6-dependent alterations in intestinal 
epithelial cell function. Journal of immunology. 2004;172(9):5616–21.
24. Paul WE. History of interleukin-4. Cytokine. 2015;75(1):3–7. [PubMed: 25814340] 
25. Goenka S, and Kaplan MH. Transcriptional regulation by STAT6. Immunol Res. 2011;50(1):87–
96. [PubMed: 21442426] 
26. Wei L, Vahedi G, Sun HW, Watford WT, Takatori H, Ramos HL, Takahashi H, Liang J, Gutierrez-
Cruz G, Zang C, et al. Discrete roles of STAT4 and STAT6 transcription factors in tuning 
epigenetic modifications and transcription during T helper cell differentiation. Immunity. 
2010;32(6):840–51. [PubMed: 20620946] 
27. Roebroek AJ, Taylor NA, Louagie E, Pauli I, Smeijers L, Snellinx A, Lauwers A, Van de Ven WJ, 
Hartmann D, and Creemers JW. Limited redundancy of the proprotein convertase furin in mouse 
liver. J Biol Chem. 2004;279(51):53442–50. [PubMed: 15471862] 
28. Bruns HA, Schindler U, and Kaplan MH. Expression of a constitutively active Stat6 in vivo alters 
lymphocyte homeostasis with distinct effects in T and B cells. J Immunol. 2003;170(7):3478–87. 
[PubMed: 12646608] 
29. Persson L A modified baermann apparatus for the recovery of infective nematode larvae from 
herbage and manure. Zentralbl Veterinarmed B. 1974;21(7):483–8. [PubMed: 4411676] 
Li et al. Page 12
J Immunol. Author manuscript; available in PMC 2019 November 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
30. Hoffmann P, Ermann J, Edinger M, Fathman CG, and Strober S. Donor-type CD4(+)CD25(+) 
regulatory T cells suppress lethal acute graft-versus-host disease after allogeneic bone marrow 
transplantation. JExpMed. 2002;196(3):389–99.
31. Setiawan T, Metwali A, Blum AM, Ince MN, Urban JF, Jr, Elliott DE, and Weinstock JV. 
Heligmosomoides polygyrus promotes regulatory T-cell cytokine production in the murine normal 
distal intestine. InfectImmun. 2007;75(9):4655–63.
32. Pillai AB, George TI, Dutt S, and Strober S. Host natural killer T cells induce an interleukin-4-
dependent expansion of donor CD4+CD25+Foxp3+ T regulatory cells that protects against graft-
versus-host disease. Blood. 2009;113(18):4458–67. [PubMed: 19221040] 
33. Pillai AB, George TI, Dutt S, Teo P, and Strober S. Host NKT cells can prevent graft-versus-host 
disease and permit graft antitumor activity after bone marrow transplantation. JImmunol. 
2007;178(10):6242–51. [PubMed: 17475852] 
34. Cooke KR, Kobzik L, Martin TR, Brewer J, Delmonte J, Jr., Crawford JM, and Ferrara JL. An 
experimental model of idiopathic pneumonia syndrome after bone marrow transplantation: I. The 
roles of minor H antigens and endotoxin. Blood. 1996;88(8):3230–9. [PubMed: 8963063] 
35. Kaplan DH, Anderson BE, McNiff JM, Jain D, Shlomchik MJ, and Shlomchik WD. Target 
antigens determine graft-versus-host disease phenotype. JImmunol. 2004;173(9):5467–75. 
[PubMed: 15494494] 
36. Carlson MJ, West ML, Coghill JM, Panoskaltsis-Mortari A, Blazar BR, and Serody JS. In vitro-
differentiated TH17 cells mediate lethal acute graft-versus-host disease with severe cutaneous and 
pulmonary pathologic manifestations. Blood. 2009;113(6):1365–74. [PubMed: 18957685] 
37. Shea-Donohue T, Sun R, Bohl JA, McLean LP, and Zhao A. Enteric nematodes and the path to up-
regulation of type 2 cytokines IL-4 and IL-13. Cytokine. 2015;75(1):62–7. [PubMed: 26188364] 
38. Carrier Y, Yuan J, Kuchroo VK, and Weiner HL. Th3 cells in peripheral tolerance. I. Induction of 
Foxp3-positive regulatory T cells by Th3 cells derived from TGF-beta T cell-transgenic mice. 
Journal of immunology. 2007;178(1):179–85.
39. Metelli A, Salem M, Wallace CH, Wu BX, Li A, Li X, and Li Z. Immunoregulatory functions and 
the therapeutic implications of GARP-TGF-beta in inflammation and cancer. J Hematol Oncol. 
2018;11(1):24. [PubMed: 29458436] 
40. Oida T, and Weiner HL. TGF-beta induces surface LAP expression on murine CD4 T cells 
independent of Foxp3 induction. PLoS One. 2010;5(11):e15523. [PubMed: 21124798] 
41. Inoue T, Ikegame K, Kaida K, Okada M, Yoshihara S, Tamaki H, Fujimori Y, Soma T, and Ogawa 
H. Host Foxp3+CD4+ Regulatory T Cells Act as a Negative Regulator of Dendritic Cells in the 
Peritransplantation Period. J Immunol. 2016;196(1):469–83. [PubMed: 26621858] 
42. Takaki H, Ichiyama K, Koga K, Chinen T, Takaesu G, Sugiyama Y, Kato S, Yoshimura A, and 
Kobayashi T. STAT6 Inhibits TGF-beta1-mediated Foxp3 induction through direct binding to the 
Foxp3 promoter, which is reverted by retinoic acid receptor. J Biol Chem. 2008;283(22):14955–
62. [PubMed: 18400747] 
43. Grainger JR, Smith KA, Hewitson JP, McSorley HJ, Harcus Y, Filbey KJ, Finney CA, Greenwood 
EJ, Knox DP, Wilson MS, et al. Helminth secretions induce de novo T cell Foxp3 expression and 
regulatory function through the TGF-beta pathway. JExpMed. 2010;207(11):2331–41.
44. Gorelik L, Fields PE, and Flavell RA. Cutting edge: TGF-beta inhibits Th type 2 development 
through inhibition of GATA-3 expression. JImmunol. 2000;165(9):4773–7. [PubMed: 11045997] 
45. Gorelik L, and Flavell RA. Abrogation of TGFbeta signaling in T cells leads to spontaneous T cell 
differentiation and autoimmune disease. Immunity. 2000;12(2):171–81. [PubMed: 10714683] 
46. Ince MN, Elliott DE, Setiawan T, Metwali A, Blum A, Chen HL, Urban JF, Flavell RA, and 
Weinstock JV. Role of T cell TGF-beta signaling in intestinal cytokine responses and helminthic 
immune modulation. Eur J Immunol. 2009;39(7):1870–8. [PubMed: 19544487] 
47. Wei J, Duramad O, Perng OA, Reiner SL, Liu YJ, and Qin FX. Antagonistic nature of T helper 1/2 
developmental programs in opposing peripheral induction of Foxp3+ regulatory T cells. Proc Natl 
Acad Sci U S A. 2007;104(46):18169–74. [PubMed: 17978190] 
48. Sanchez-Guajardo V, Tanchot C, O’Malley JT, Kaplan MH, Garcia S, and Freitas AA. Agonist-
driven development of CD4+CD25+Foxp3+ regulatory T cells requires a second signal mediated 
by Stat6. J Immunol. 2007;178(12):7550–6. [PubMed: 17548589] 
Li et al. Page 13
J Immunol. Author manuscript; available in PMC 2019 November 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
49. Paul WE. What determines Th2 differentiation, in vitro and in vivo? Immunol Cell Biol. 
2010;88(3):236–9. [PubMed: 20157328] 
50. Mantel PY, Kuipers H, Boyman O, Rhyner C, Ouaked N, Ruckert B, Karagiannidis C, Lambrecht 
BN, Hendriks RW, Crameri R, et al. GATA3-driven Th2 responses inhibit TGF-beta1-induced 
FOXP3 expression and the formation of regulatory T cells. PLoS Biol. 2007;5(12):e329. [PubMed: 
18162042] 
51. Wohlfert EA, Grainger JR, Bouladoux N, Konkel JE, Oldenhove G, Ribeiro CH, Hall JA, Yagi R, 
Naik S, Bhairavabhotla R, et al. GATA3 controls Foxp3(+) regulatory T cell fate during 
inflammation in mice. J Clin Invest. 2011;121(11):4503–15. [PubMed: 21965331] 
52. Chen ML, Yan BS, Bando Y, Kuchroo VK, and Weiner HL. Latency-associated peptide identifies a 
novel CD4+CD25+ regulatory T cell subset with TGFbeta-mediated function and enhanced 
suppression of experimental autoimmune encephalomyelitis. Journal of immunology. 
2008;180(11):7327–37.
53. Yu Q, and Stamenkovic I. Cell surface-localized matrix metalloproteinase-9 proteolytically 
activates TGF-beta and promotes tumor invasion and angiogenesis. Genes Dev. 2000;14(2):163–
76. [PubMed: 10652271] 
54. Worthington JJ, Fenton TM, Czajkowska BI, Klementowicz JE, and Travis MA. Regulation of 
TGFbeta in the immune system: an emerging role for integrins and dendritic cells. 
Immunobiology. 2012;217(12):1259–65. [PubMed: 22902140] 
55. Fenton TM, Kelly A, Shuttleworth EE, Smedley C, Atakilit A, Powrie F, Campbell S, Nishimura 
SL, Sheppard D, Levison S, et al. Inflammatory cues enhance TGFbeta activation by distinct 
subsets of human intestinal dendritic cells via integrin alphavbeta8. Mucosal Immunol. 
2017;10(3):624–34. [PubMed: 27782111] 
56. Annes JP, Munger JS, and Rifkin DB. Making sense of latent TGFbeta activation. J Cell Sci. 
2003;116(Pt 2):217–24. [PubMed: 12482908] 
57. Schramm C, Huber S, Protschka M, Czochra P, Burg J, Schmitt E, Lohse AW, Galle PR, and 
Blessing M. TGFbeta regulates the CD4+CD25+ T-cell pool and the expression of Foxp3 in vivo. 
Int Immunol. 2004;16(9):1241–9. [PubMed: 15249539] 
58. Travis MA, Reizis B, Melton AC, Masteller E, Tang Q, Proctor JM, Wang Y, Bernstein X, Huang 
X, Reichardt LF, et al. Loss of integrin alpha(v)beta8 on dendritic cells causes autoimmunity and 
colitis in mice. Nature. 2007;449(7160):361–5. [PubMed: 17694047] 
Li et al. Page 14
J Immunol. Author manuscript; available in PMC 2019 November 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Figure 1. Helminthic promotion of the survival of BMT recipients requires recipient STAT6.
Kaplan-Meier survival curves of Heligmodomoides polygyrus bakeri (Hpb)-infected or 
uninfected STAT6–/– or WT BALB/c male recipients that received T cell-depleted (TCD-
BM) cells (TCD BM) only or TCD-BM and total splenic T cells (TCD-BM + T) from 5–6 
week-old male WT C57BL/6 mice. Cumulative data from multiple independent experiments 
(N: cumulative number of mice for each group) where STAT6−/− or WT BALB/c recipients 
received donor cells in parallel; p:NS between uninfected and Hpb-infected STAT6−/− 
recipients of TCD-BM + T donor cells; p<0.01 between uninfected and Hpb-infected WT 
BALB/c recipients of TCD-BM + T donor cells.
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Figure 2. Helminthic suppression of GVHD-related organ damage requires recipient STAT6.
Histopathology of lung (A) and colonic (B-C) tissues from uninfected and Hpb-infected 
STAT6–/– or WT BALB/c BMT mice six days after BMT. Histopathological analysis was 
performed in 6-μm-thick, hematoxylin-and-eosin-stained samples. (D) Severity of 
inflammation in lung and colon, with scoring as described in Materials and Methods. 
GVHD-related colitis was characterized by mononuclear cell infiltrates, apoptotic cells 
filling crypts (black arrows) and apoptotic bodies (white arrows). Dot plot distribution with 
mean of cumulative data from multiple samples. Each dot represents a single sample and the 
bars the mean values (N=number of samples; p: NS between uninfected (Uninf; black filled 
dots) and Hpb-infected (white empty dots) STAT6−/− recipients; p<0.05 between uninfected 
(Uninf; black filled dots) and Hpb-infected (white empty dots) WT BALB/c recipients).
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Figure 3. Helminthic suppression of inflammatory cytokine generation in GVHD requires host 
STAT6.
IFNγ and TNFα concentrations in donor T cells (upper panels) and serum (lower panels) of 
uninfected control (black filled dots) and Hpb-infected (white empty dots) STAT6–/– or WT 
(BALB/c) BMT recipients (N=the number of mice) six days after BMT. Cytokine 
concentrations were analyzed by ELISA, and results are displayed as mean with dot plot 
distribution. Dot plot distribution with mean of multiple samples (N) with each dot 
representing the mean for a single sample from multiple determinations (≥3) and each bar 
representing the mean from multiple samples; p values are provided in each panel.
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Figure 4. Helminth-induced generation of active TGFβ requires STAT6.
Mesenteric lymph node (MLN) T cells from Hpb-infected and uninfected 8–9 week-old 
male STAT6–/– or WT (BALB/c) mice were cultured in vitro with plate-bound anti-CD3 and 
soluble anti-CD28 for 48 hours. Supernatants were analyzed for TGFβ cytokine content by 
ELISA. Dot plot distribution with mean of multiple samples (N) with each dot representing 
the mean for a single sample from multiple determinations (≥3) and each bar representing 
the mean from multiple samples; p values are provided in each panel.
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Figure 5. Helminth-induced expression of pro-TGFβ requires STAT6.
Freshly isolated splenic and MLN cells from Hpb-infected and uninfected 8–9 week-old 
male STAT6–/– or WT (BALB/c) mice were stained for CD3, CD4, Foxp3 and latency-
associated peptide (LAP) or CD3, CD4, Foxp3 and control IgG. (A) Histograms showing 
mean fluorescence intensity (MFI) of LAP or control IgG staining on Foxp3+ CD4 or 
Foxp3- CD4 T cells from Hpb-infected (white empty dots) or uninfected (black filled dots) 
mice. (B) Dot plots representing cumulative data from experiments as in A, showing mean
±SD for LAP staining from several independent determinations (N: the number of 
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independent determinations; p values as indicated on the figure). (C) TGFβ mRNA content 
in purified splenic or MLN CD4 T cells from uninfected (Black rectangles) or helminth-
infected (white rectangles) STAT6−/− or WT BALB/c mice were displayed as the ratio of 
TGFβ mRNA to HPRT mRNA. (N: number of independent measurements; p: not significant 
between uninfected and helminth-infected groups). (D) Spleen and MLN cells from 
uninfected and helminth-infected STAT6−/− or WT BALB/c mice were stained for CD3, 
CD4, Foxp3 and GARP. Cells were gated on CD3+ CD4+ T cells. Numbers represent the 
percentage of events in each quadrant. Data are representative example from at least two 
samples for each set.
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Figure 6. Helminth-induced increase in percentage of Foxp3+ Tregs requires host cell STAT6.
Representative dot plot FACS analysis from spleen (upper rows) and MLN (lower rows) 
cells isolated from uninfected (Uninf) and Hpb-infected (Hpb) STAT6–/– or WT (BALB/c) 
mice 6 days after BMT. Spleen and MLN cells were stained for CD3, CD4, H2b, H2d and 
Foxp3. Cells were gated on donor or host CD3+ T cells. Numbers represent the percentage 
of events in each quadrant.
Li et al. Page 21
J Immunol. Author manuscript; available in PMC 2019 November 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Figure 7. Helminth-induced increase in Foxp3+ Treg percentage and number requires host cell 
STAT6 signaling.
Data from multiple samples (N) analyzed as detailed in Figure 6, displayed as dot-plot 
distribution with means (bar), showing percentage (A) or number (B) of Foxp3+ CD4 Tregs. 
(A) Each dot represents the percentage of donor Foxp3+ donor CD4 Tregs among total 
donor T cells or the percentage of host (recipient) Foxp3+ CD4 Tregs among total host 
(recipient) T cells. P values as shown in each graph between Hpb-infected (Hpb; white 
empty dots) vs. uninfected (Uninf; black filled dots) groups. (B) The total number of splenic 
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Foxp3+ CD4 Tregs (donor or host (recipient)-derived) was calculated from the percentage of 
donor or host Tregs and the number of cells isolated from a single spleen. The total number 
of MLN Foxp3+ CD4 Tregs (donor or host (recipient)-derived) was calculated from the 
percentage of donor or host Tregs and the number of cells isolated from MLN of a single 
mouse or pooled MLN from multiple mice. Each dot represents one experiment with bars 
representing mean values from multiple experiments. Left side Y-axis shows data for splenic 
cell analysis, whereas right-sided Y axis displays the results from MLN cell analysis.
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Figure 8. Continuous expression of active STAT6 in T cells is sufficient to stimulate the 
expression of pro-TGFβ.
(A) Mean fluorescence intensity of LAP staining on Foxp3+ CD4+ and Foxp3- CD4+ T cells 
from spleen and MLN of STAT6 VT (STAT6 VT+; white histograms) mice and WT (STAT6 
VT-) littermates (gray histograms). (B) Cumulative data showing mean±SD from several 
experiments (n: the number of independent experiment. Each dot represents a single 
experiment with bars representing mean values from multiple experiments; p value as 
indicated in each panel). (C) TGFβ mRNA content in purified splenic or MLN CD4 T cells 
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from STAT6 VT- (Black rectangles) or STAT6 VT+ (white rectangles) mice were displayed 
as the ratio of TGFβ mRNA to HPRT mRNA. (N: number of independent measurements; p: 
not significant between STAT6 VT- and STAT6 VT+ groups). (D) Spleen and MLN cells 
from uninfected and helminth-infected STAT6 VT+ (VT(+)) or STAT6 VT- (VT(−)) mice 
were stained for CD3, CD4, Foxp3 and GARP. Cells were gated on CD3+ CD4+ T cells. 
Numbers represent the percentage of events in each quadrant. Data are representative 
example from three samples for each set.
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Figure 9. Furin expression by T cells is necessary for the generation of active TGFβ but not for 
pro-TGFβ.
(A) Dot plots showing TGFβ concentration in MLN T cells isolated from uninfected (black 
filled dots) or Hpb-infected (white empty dots) STAT6 VT+ and VT- mice, as assessed by 
TGFβ ELISA using supernatants from 48-hr anti-CD28 stimulated cultures. Cumulative data 
from several independent experiments. Dot plot distribution with mean of multiple samples 
(N) with each dot representing the mean for a single sample from multiple determinations 
(≥3) and each bar representing the mean from multiple samples; p values are provided in 
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each panel. (B) Dot plot distribution of TGFβ concentration in MLN T cells isolated from 
uninfected (black filled dots) or Hpb-infected (white empty dots) furin-expressing (Cre-) or 
furin-deficient (Cre+) mice, as assessed by TGFβ ELISA as described in A. Dot plot 
distribution with mean of multiple samples (N) with each dot representing the mean for a 
single sample from multiple determinations (≥3) and each bar representing the mean from 
multiple samples; p values as shown; BD: below detection. (C) Dot plot distribution of IL4 
concentration - as measured by ELISA - in MLN T cells isolated and cultured as in Figure 
9B. Dot plot distribution with mean of multiple samples (N) with each dot representing the 
mean for a single sample from multiple determinations (≥3) and each bar representing the 
mean from multiple samples; p values as shown; BD: below detection. (D) LAP expression 
(bold) compared to isotype control antibody staining (dashed) in furin deficient (Cre+) 
uninfected or Hpb-colonized MLN T cells (representative example from 3 independent 
experiments). (E) Furin mRNA content in purified splenic or MLN CD4 T cells from 
uninfected (Black rectangles) or helminth-infected (white rectangles) STAT6−/− or WT 
BALB/c mice were displayed as the ratio of furin mRNA to HPRT mRNA. (N: number of 
independent measurements; p: not significant between uninfected and helminth-infected 
groups, unless indicated otherwise on the figure). (F) Furin mRNA content in purified 
splenic or MLN CD4 T cells from STAT6 VT- (Black rectangles) or STAT6 VT+ (white 
rectangles) mice were displayed as the ratio of TGFβ mRNA to HPRT mRNA. (N: number 
of independent measurements; p: not significant between STAT6 VT- and STAT6 VT+ 
groups).
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Table 1:
Primers used for RT-qPCR
Gene Sequences (5’−3’) Fragment size (bp)
HPRT F: TGAAGAGCTACTGTAATGATCAGTCAAC 186 
 R: GCAAGCTTGCAACCTTAACCAT   
TGFβ F: TGACGTCACTGGAGTTGTACGG 170 
 R: GGTTCATGTCATGGATGGTGC  
Furin  F: CATGACTACTCTGCTGATGG 148 
 R: GAACGAGAGTGAACTTGGTC  
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